GILD vs HTB · P/E 18, rev $7.80B vs P/E 12, rev $122.7M
Gilead Sciences Inc (GILD) versus HomeTrust Bancshares, Inc. (HTB) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
HomeTrust Bancshares, Inc. (HTB) is a banks - regional company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported HTB revenue for 2026-06-30 was $122.7M. Net income was $32.4M. Revenue was up 99.5% from 2026-03-31 to 2026-06-30. HTB currently screens at market cap $793.5M and trailing P/E 12.2.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. HTB currently screens at market cap $793.5M and trailing P/E 12.2.
Not investment advice. Open the GILD and HTB stock pages for the full models.
Not investment advice.